These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Nauck M Diabetes Obes Metab; 2016 Mar; 18(3):203-16. PubMed ID: 26489970 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Effects of Incretin-Based Therapies. White WB; Baker WL Annu Rev Med; 2016; 67():245-60. PubMed ID: 26768240 [TBL] [Abstract][Full Text] [Related]
8. Differentiating incretin-based therapies for population-based health care. Calabrese D Am J Manag Care; 2011 Mar; 17(2 Suppl):S52-8. PubMed ID: 21517657 [TBL] [Abstract][Full Text] [Related]
9. Incretin-based therapies and cardiovascular risk. Mannucci E; Dicembrini I Curr Med Res Opin; 2012 May; 28(5):715-21. PubMed ID: 22439700 [TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet. Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N Endocrinology; 2012 Aug; 153(8):3878-85. PubMed ID: 22621958 [TBL] [Abstract][Full Text] [Related]
11. Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats. Tanajak P; Pintana H; Siri-Angkul N; Khamseekaew J; Apaijai N; Chattipakorn SC; Chattipakorn N J Endocrinol; 2017 Feb; 232(2):189-204. PubMed ID: 27875248 [TBL] [Abstract][Full Text] [Related]
12. DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats. Freyse EJ; Berg S; Kohnert KD; Heinke P; Salzsieder E Biol Chem; 2011 Mar; 392(3):209-15. PubMed ID: 21281062 [TBL] [Abstract][Full Text] [Related]
13. Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance. Abdesselam I; Pepino P; Troalen T; Macia M; Ancel P; Masi B; Fourny N; Gaborit B; Giannesini B; Kober F; Dutour A; Bernard M J Cardiovasc Magn Reson; 2015 Nov; 17():95. PubMed ID: 26546347 [TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats. Zhou X; Huang CH; Lao J; Pocai A; Forrest G; Price O; Roy S; Kelley DE; Sullivan KA; Forrest MJ Cardiovasc Diabetol; 2015 Mar; 14():29. PubMed ID: 25888997 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance. Sjøberg KA; Rattigan S; Jeppesen JF; Lundsgaard AM; Holst JJ; Kiens B J Physiol; 2015 May; 593(9):2185-98. PubMed ID: 25688993 [TBL] [Abstract][Full Text] [Related]
16. I Nascimento AR; Gomes F; Machado MV; Gonçalves-de-Albuquerque C; Bousquet P; Tibiriçá E Auton Neurosci; 2019 Mar; 217():18-25. PubMed ID: 30704971 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice. Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859 [TBL] [Abstract][Full Text] [Related]
18. Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice. Porter D; Faivre E; Flatt PR; Hölscher C; Gault VA Peptides; 2012 May; 35(1):1-8. PubMed ID: 22465882 [TBL] [Abstract][Full Text] [Related]
19. Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus. Campbell RK Clin Ther; 2011 May; 33(5):511-27. PubMed ID: 21665040 [TBL] [Abstract][Full Text] [Related]
20. DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats. Sivasinprasasn S; Tanajak P; Pongkan W; Pratchayasakul W; Chattipakorn SC; Chattipakorn N Sci Rep; 2017 Mar; 7():44306. PubMed ID: 28281660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]